Clostridium perfringens ɛ-toxin

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 631-642

  Basak, Ajit K ^a   Popoff, M ^b   Titball, R W ^c   Cole, Ambrose ^c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUT PASTEUR   (France)

^c DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449370674     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50040-8     Document Type: Chapter

References (69)

1. Abrami L., van Der Goot F.G. Plasma membrane microdomains act as concentration platforms to facilitate intoxication by aerolysin. J. Cell. Biol. 1999, 147:175-184.
2. Atlas R.M. Biological weapons pose challenge for microbiology community. ASM News. Vol. 1998, 64:383-389.
3. Bhown A.S., Habeeb A.F. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon toxin. Biochem. Biophys. Res. Commun. 1977, 78:889-896.
4. Borrmann E., Schulze F., Diller R. Development of in vitro methods for the potency testing of clostridial vaccines. Altex. 2001, 18:34-36.
5. Bowmann E. Iraqi chemical and biological weapons capabilities. Congressional Research Service 1998, 1-5. Washington, DC.
6. Brooks M.E., Sterne M., Warrack G.H. A reassessment of the criteria used for type differentiation of Clostridia perfringens. J. Pathol. Bacteriol. 1957, 74:185-195.
7. Bullen J.J. Role of toxin in host-parasite relationship. Microbial Toxins 1970, 233-276. Academic Press, Washington DC. S. Ajl, S. Kadis (Eds.).
8. Buxton D., MacLeod N.S.M., Nicolson T.B. Focal symmetrical encephalomalacia in young cattle, caused by Clostridium welchii. Vet. Rec. 1981, 108:459.
9. Buxton D., Morgan K.T. Studies of lesions produced in the brains of colostrum-deprived lambs by Clostridium welchii (Cl. perfringens) type D toxin. J. Comp. Pathol. 1976, 86:435-447.
10. Canard B., Saint-Joanis B., Cole S.T. Genomic diversity and organization of virulence genes in the pathogenic anaerobe Clostridium perfringens. Mol. Microbiol. 1992, 6:1421-1429.
11. Cole A.R., Gibert M., Popoff M., Moss D.S., Titball R.W., Basak A.K. Clostridium perfringens epsilson toxin shows structural similarity to the pore-forming toxin aerolysin. Nat. Struct. Mol. Biol. 2004, 11:797-798.
12. Cordesman UNSCOM Main Achievements: United Nations Special Commission (UNSCOM) 1998, 67-91.
13. Donelli G., Fiorentini C., Matarresa P., Falzano L., Cardines R., Mastrantonio P., Payne D., Titball R.W. Evidence for cytoskeletal changes secondary to plasma membrane functional alterations in the in vitro cell response to Clostridium perfringens epsilson toxin. Microbiology and Infectious Disease 2003, 26:145-156.
14. Finnie J.W. Histopathological changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J. Comp. Pathol. 1984, 94:445-452.
15. Fivaz M., Abrami L., Tsitrin Y., van der Goot F.G. Not as simple as just punching a hole. Toxicon. 2001, 39:1637-1645.
16. Gardner D.E. Pathology of Clostridium welchii type D enterotoxaemia. I. Biochemical and hematological alterations in lambs. J. Comp. Pathol. 1973, 83:499-507.
17. Gill D.M. Bacterial toxins: a table of lethal amounts. Microb. Rev. 1982, 46:86-94.
18. Griner L.A., Aichelman W.W., Brown G.D. Clostridium perfringens type D (epsilon) enterotoxemia in Brown Swiss dairy calves. J. Am. Vet. Med. Assoc. 1956, 129:375-376.
19. Hambrook J.L., Lindsay C.D., Hughes N. Morphological alterations in MDCK cells induced by exposure to Clostridium perfringens epsilon toxin. Biochem. Soc. Trans. 1995, 23:44S.
20. Hartley W.J. A focal encephalomalacia of lambs. N. Z. Vet. J. 1956, 4:129-135.
21. Havard H.L., Hunter S.E., Titball R.W. Comparison of the nucleotide sequence and development of a PCR test for the epsilon toxin gene of Clostridium perfringens type B and type D. FEMS Microbiol. Lett. 1992, 76:77-81.
22. Hunter S.E., Clarke I.N., Kelly D.C., Titball R.W. Cloning and nucleotide sequencing of the Clostridium perfringens epsilon toxin gene and its expression in Escherichia coli. Infect. Immun. 1992, 60:102-110.
23. Jin F., Matsushita O., Katayama S., Jin S., Matsushita C., Minami J., Okabe A. Purification, characterization, and primary structure of Clostridium perfringens lambda-toxin, a thermolysin-like metalloprotease. Infect. Immun. 1996, 64:230-237.
24. Johnson E.A. Extrachromosomal virulence determinants in the clostridia. The Clostridia: Molecular Biology and Pathogenesis 1997, 35-48. Academic Press, New York. J.I. Rood, B. McClane, J.G. Songer, R.W. Titball (Eds.).
25. Jubb K.V.F., Kennedy P.C., Palmer N. Pathology of domestic animals 1993, Academic Press, London.
26. Knight P.A., Queminet J., Blanchard J.H., Tilleray J.H. In vitro tests for the measurement of clostridial toxins, toxoids, and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture. Biologicals. 1990, 18:263-270.
27. Laetitia P., Gilbert M., Popoff M.R. Clostridium perfringens: toxinotype and genotype. Trends in Microbiol. 1999, 7:104-110.
28. Lindsay C.D. Assessment of aspects of the toxicity of Clostridium perfringens epsilon toxin using the MDCK cell line. Hum. Exp. Toxicol. 1996, 15:904-908.
29. Lindsay J.A. Clostridium perfringens type A enterotoxin (CPE): more than just explosive diarrhea. Crit. Rev. Microbiol. 1996, 22:257-277.
30. Liu J.W., Porter A.G., Wee B.Y., Thanabalu T. New gene from nine Bacillus sphaericus strains encoding highly conserved 35.8-kilodalton mosquitocidal toxins. Appl. Environ. Microbiol. 1996, 62:2174-2176.
31. MacKenzie C.R., Hirama T., Buckley J.T. Analysis of receptor binding by the channel-forming toxin aerolysin using surface plasmon resonance. J. Biol. Chem. 1999, 274:22604-22609.
32. McDonel J.L. Toxins of Clostridium perfringens types A, B, C, D and E. Pharmacology of Bacterial Toxins 1986, 477-517. Pergamon Press, London. F. Dorner, J. Drews (Eds.).
33. Melton J.A., Parker M.W., Rossjohn J., Buckley J.T., Tweten R.K. The identification and structure of the membrane-spanning domain of the Clostridium septicum alpha toxin. J. Biol. Chem. 2004, 279:14315-14322.
34. Minami J., Katayama S., Matsushita O., Matsushita C., Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon toxin by releasing its N- and C-terminal peptides. Microbiol. Immunol. 1997, 41:527-535.
35. Miyamoto O., Minami J., Toyoshima T., Nakamura T., Masada T., Nagao S., Negi T., Itano T., Okabe A. Neurotoxicity of Clostridium perfringens epsilon toxin for the rat hippocampus via the glutamatergic system. Infect. Immun. 1998, 66:2501-2508.
36. Miyamoto O., Sumitani K., Nakamura T., Yamagami S., Miyata S., Itano T., Negi T., Okabe A. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol. Lett. 2000, 189:109-113.
37. Miyata S., Matsushita O., Minami J., Katayama S., Shimamoto S., Okabe A. Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon toxin in the synaptosomal membrane. J. Biol. Chem. 2001, 276:13778-13783.
38. Miyata S., Minami J., Tamai E., Matsushita O., Shimamoto S., Okabe A. Clostridium perfringens epsilon toxin forms a heptameric pore within the detergent-insoluble microdomains of MDCK cells and rat synaptosomes. J. Biol. Chem. 2002, 277:39463-39468.
39. Moniatte M., van der Goot F.G., Buckley J.T., Pattus F., Van Dorselaer A. Characterization of the heptameric poreforming complex of the Aeromonas toxin Aerolysin using MALDI-TOFF mass spectrometry. FEBS Lett. 1996, 384:269-272.
40. Nagahama M., Michiue K., Mukai M., Ochi S., Sakurai J. Mechanism of membrane damage by Clostridium perfringens alpha-toxin. Microbiol. Immunol. 1998, 42:533-538.
41. Nagahama M., Sakurai J. High-affinity binding of Clostridium perfringens epsilon toxin to rat brain. Infect. Immun. 1992, 60:1237-1240.
42. Nagahama M., Sakurai J. Effect of drugs acting on the central nervous system on the lethality in mice of Clostridium perfringens epsilon toxin. Toxicon 1993, 31:427-435.
43. Niilo L. Clostridium perfringens. Pathogenesis of Bacterial Infections in Animals 1993, 114-123. I.S.U Press, Oxford. C.L. Gyles, C.O. Thoen (Eds.).
44. Ohnishi M., Hayashi T., Tomita T., Terawaki Y. Mechanism of the cytolytic action of Pseudomonas aeruginosa cytotoxin: oligomerization of the cytotoxin on target membranes. FEBS Lett 1994, 356:357-360.
45. Oyston P.C., Payne D.W., Havard H.L., Williamson E.D., Titball R.W. Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon toxin, which induces protective immunity in mice. Microbiology 1998, 144:333-341.
46. Parker M.W., Buckley J.T., Postma J.P., Tucker A.D., Leonard K., Pattus F., Tsernoglou D. Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states. Nature 1994, 367:292-295.
47. Payne D., Oyston P. The Clostridium perfringens ε-Toxin. The Clostridia: Molecular Biology and Pathogensis 1997, Academic Press. J.I. Rood, B.A. McClane, J.G. Songer, R.W. Triball (Eds.).
48. Payne D.W., Williamson E.D., Havard H., Modi N., Brown J. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol. Lett. 1994, 116:161-167.
49. Percival D.A., Shuttleworth A.D., Williamson E.D., Kelly D.C. Anti-idiotypic antibody-induced protection against Clostridium perfringens type D. Infect. Immun. 1990, 58:2487-2492.
50. Petit L., Gibert M., Gillet D., Laurent-Winter C., Boquet P., Popoff M.R. Clostridium perfringens epsilon toxin acts on MDCK cells by forming a large membrane complex. J. Bacteriol. 1997, 179:6480-6487.
51. Petit L., Maier E., Gibert M., Popoff M.R., Benz R. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J. Biol. Chem. 2001, 276:15736-15740.
52. Popoff M. Bacteriological examination in enterotoxaemia of sheep and lamb. Vet. Rec. 1984, 114:324.
53. Rood J.I. Virulence genes of Clostridium perfringens. Annu. Rev. Microbiol. 1998, 52:333-360.
54. Sakurai J., Nagahama M. Tryptophan content of Clostridium perfringens epsilon toxin. Infect. Immun. 1985, 47:260-263.
55. Sakurai J., Nagahama M. Histidine residues in Clostridium perfringens epsilon toxin. FEMS Microbiol. Lett. 1987, 41:317-319.
56. Sakurai J., Nagahama M. The inactivation of Clostridium perfringens epsilon toxin by treatment with tetranitromethane and N-acetylimidazole. Toxicon. 1987, 25:279-284.
57. Shimizu T., Ohtani K., Hirakawa H., Ohshima K., Yamashita A., Shiba T., Ogasawara N., Hattori M., Kuhara S., Hayashi H. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl. Acad. Sci. USA 2002, 99:996-1001. No(2).
58. Smith L.D.S., Williams B.L. The Pathogenic Anaerobic Bacteria 1984, Springfield, IL. 3rd ed. C. Thomas (Ed.).
59. Song L., Gouaux E. Crystallization of the alpha-hemolysin heptamer solubilized in decyldimethyl- and decyldiethylphosphine oxide. Acta Crystallogr D Biol Crystallogr 1998, 54:276-278. (Pt 2).
60. Songer J.G. Clostridial enteric diseases of domestic animals: a review. Clin. Microbiol. Rev. 1996, 9:216-234.
61. Starr B. UNSCOM inspectors still doubt Iraq's arms claims. Jane's Defence Weekly 1998, 18.
62. Thanabalu T., Porter A.G. A Bacillus sphaericus gene encoding a novel type of mosquitocidal toxin of 31.8 kDa. Gene 1996, 170:85-89.
63. Uzal F.A., Kelly W.R. Effects of the intravenous administration of Clostridium perfringens type D epsilon toxin on young goats and lambs. J. Comp. Pathol. 1997, 116:63-71.
64. Uzal F.A., Kelly W.R. Protection of goats against experimental enterotoxaemia by vaccination with Clostridium perfringens type D epsilon toxoid. Vet. Rec. 1998, 142:722-725.
65. Waheed A.A., Shimada Y., Heijnen H.F., Nakamura M., Inomata M., Hayashi M., Iwashita S., Slot J.W., Ohno-Iwashita Y. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl. Acad. Sci. USA 2001, 98:4926-4931.
66. Wilmsen H.U., Leonard K.R., Tichelaar W., Buckley J.T., Pattus F. The aerolysin membrane channel is formed by heptamerization of the monomer. EMBO. J. 1992, 11:2457-2463.
67. Worthington R.W., Bertschinger H.J., Mulders M.S. Catecholamine and cyclic nucleotide response of sheep to the injection of Clostridium welchii type D epsilon toxin. J. Med. Microbiol. 1979, 12:497-501.
68. Worthington R.W., Mulders M.S. Effect of Clostridium perfringens epsilon toxin on the blood brain barrier of mice. Onderstepoort. J. Vet. Res. 1975, 42:25-27.
69. Worthington R.W., Mulders M.S. Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation. Infect. Immun. 1977, 18:549-551.